Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
The firm is currently investigating Pradaxa lawsuits on behalf of individuals who suffered life-threatening episodes of internal bleeding, allegedly due to Pradaxa.
New York, New York (PRWEB) July 25, 2013
Pradaxa lawsuit claims continue to move forward in the federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. Court records indicate that the litigation’s most recent Status Conference was held on July 9th, at which time the appointment of a special master for depositions was discussed, as was the scheduling of depositions for the proceedings’ bellwether trials. The Court also scheduled the Pradaxa bleeding litigation’s next Status Conference for August 8, 2013. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We continue to hear from alleged victims of Pradaxa bleeding side effects. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.
Pradaxa Bleeding Lawsuits
Court documents indicate that more than 1,250 Pradaxa lawsuits have been filed in the Southern District of Illinois, all of which allege that Boehringer Ingelheim failed to provide adequate warnings regarding the drug’s side effects, particularly the lack of an antidote for Pradaxa bleeding. The first bellwether trial in the Pradaxa bleeding litigation is scheduled to start in September 2014.
Pradaxa was approved in October 2010 to treat patients with atrial fibrillation. However, since Pradaxa came on the market, the drug has been the subject of regulatory warnings in several countries, according to Bloomberg.com. While it was touted as an improvement over warfarin, there exists no readily available antidote for reversing the life-threatening internal bleeding that can sometimes occur in Pradaxa patients.* Most recently, a study published by the Institute for Safe Medicine Practices (ISMP) reported that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.**
Pradaxa patients who have suffered serious episodes of internal bleeding may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa lawsuits is available at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.
*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, 12-11-2012
**ismp.org/quarterwatch/pdfs/2012Q2.pdf, ISMP January 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
For the original version on PRWeb visit: http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-bleeding/prweb10965666.htm